Skip to content

Brepocitinib tied to better dermatomyositis skin and itch

August 29, 2026 · 13 min

Show notes

Editor's Pick: Skin-Specific Outcomes of Brepocitinib in Patients With Dermatomyositis: Secondary Analysis of a Phase 3 Randomized Clinical Trial (JAMA Dermatology, 2026)

Welcome to This Week in Dermatology. This week we're covering 10 notable papers spanning systemic drug safety and the cardiometabolic interface, new targeted therapy data in inflammatory and neutrophilic skin disease, risk stratification in skin cancer, and a pair of papers that together make a strong case for looking below the neck in acne. Let's dive in.

This week's papers:

  1. Cardiometabolic Associations of Dermatological Treatments. Part I: Systemic Therapies.. Journal of the American Academy of Dermatology 2026
  2. Cardiometabolic Associations of Dermatological Treatments. Part II: Targeted and Biologic Therapies.. Journal of the American Academy of Dermatology 2026
  3. Skin-Specific Outcomes of Brepocitinib in Patients With Dermatomyositis: Secondary Analysis of a Phase 3 Randomized Clinical Trial.. JAMA Dermatology 2026
  4. A Delphi Consensus on Tildrakizumab Dosing and Titration in Moderate-to-Severe Plaque Psoriasis.. Acta Dermato-Venereologica 2026
  5. Validation of the integrated 40-gene expression profile (i40-GEP) which provides prognostic and adjuvant radiation benefit for high-risk cutaneous squamous cell carcinoma.. Journal of the American Academy of Dermatology 2026
  6. Comorbidity-Guided Management of Pyoderma Gangrenosum: A Clinical Guide to Emerging Therapeutic Targets.. Journal of the American Academy of Dermatology 2026
  7. Global Disparities in Access to Dermatological Care.. JAMA Dermatology 2026
  8. Laser and Energy-Based Device Use in Skin of Color: A Clinical Review of Safety, Efficacy, and Best Practices.. Journal of the American Academy of Dermatology 2026
  9. Truncal Acne Is Independently Associated with Stigmatization, Poorer Treatment Adherence and Greater Healthcare Utilization: A 20-country Survey.. Acta Dermato-Venereologica 2026
  10. Effectiveness, safety and tolerability of Ozenoxacin 2% lotion vs Clindamycin 1% lotion in mild to moderate truncal acne: An open label randomized controlled clinical trial.. Clinical and Experimental Dermatology 2026

Listen at AudioScholar

All episodes of AudioScholar Dermatology Weekly (India)

Settings

Display

Language

Decides which stations you see first on the home page.

History

Recently played stations and episodes and your latest searches are only stored in this browser.

Notifications

A short notice when a podcast you follow has a new episode. Turn off single podcasts with the bell on their page.

Account

Save favorites – in the app and on the website.

Keyboard shortcuts

/
Open search
Space
Play or pause
← →
In the player: back 15 s, forward 30 s (episodes) · in a row: next tile
↑ ↓
In a row: target within the tile
Home / End
In a row: first or last tile
Esc
Close window or menu
?
This overview
Now playing

Go to station page

Play next

    Add episodes with “Play next” – they play after the current episode.